• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Genetics Market
    Genetics News
    Genetics Stocks
    • Genetics Market
    • Genetics News
    • Genetics Stocks

    New Study Offers Insight Into DiGeorge Syndrome

    Morag Mcgreevey
    Jul. 28, 2015 04:08PM PST
    Genetics Investing

    Children with DiGeorge syndrome, a disorder in which several genes on the 22nd chromosome are deleted, often grow up to develop psychosis or autism spectrum disorder. A new study may help researchers predict which path a child with DeGeorge syndrome may take.

    Children with DiGeorge syndrome, a disorder in which several genes on the 22nd chromosome are deleted, often grow up to develop psychosis or autism spectrum disorder. A new study may help researchers predict which path a child with DeGeorge syndrome may take.
    According to an article on PsychCentral:

    In a new study, researchers at the University of California, Los Angeles (UCLA) and the University of Pittsburgh are the first to suggest a potential way to make that determination in patients with DiGeorge syndrome, also known as 22q11.2 deletion syndrome. They report having isolated specific genetic differences between those with autism and those with psychosis.
    Between 30 and 40 percent of individuals with DiGeorge syndrome are diagnosed with a disorder on the autism spectrum, and between 25 and 30 percent are diagnosed with a psychotic disorder. A small number are diagnosed with both autism and psychosis.

    Dr. Carrie Bearden, the study’s senior author and a professor of psychiatry and psychology at UCLA, said:

    Ultimately, this kind of information could be used as a diagnostic tool that could allow pediatricians or other clinicians to determine who will develop which disorder, so that the appropriate intervention can be applied — and applied early enough to have the most impact.

    Click here to read the entire article on PsychCentral.
     

    The Conversation (0)

    Go Deeper

    AI Powered
    illustration of brain and cell phone.

    BlinkLab Completes First Patient Test for US Autism Diagnostic Study

    A floating DNA double helix above a hand with a blue background.

    Top 5 NASDAQ Genetics Stocks (Updated January 2025)

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Genetics Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×